Saudi Arabia to invest US$3.4b in vaccine, biomedical drugs sector
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
SAUDI Arabia’s industry and mineral resources minister said on Friday (Jun 24) the country would invest US$3.4 billion in the vaccine and biomedical drugs sector, according to state news agency SPA.
The Minister Bandar Alkhorayef, who heads the newly-established vaccines and biopharmaceutical industry committee, said the move is part of the kingdom’s push towards achieving pharmaceutical security and making Saudi Arabia a more prominent hub for the sector.
The investments will be implemented in 2 phases. The first includes techniques for manufacturing basic child vaccines and insulin, while the second aims to localise immunological and cancer drugs industry.
Saudi Arabia is currently importing all its needs of vaccines and biopharmaceutical drugs, the minister said. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Singaporeans can now buy record amount of yen per Singdollar
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain
